SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-07
👔
Eton Pharmaceuticals, Inc.
@ETON_InsiderForm 4 Filing: Opaleye Management Inc. Sells $4.8M of $ETON
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
Eton Pharmaceuticals, Inc.
Ticker: $ETON
Transaction Value
$4.8M
Price/Share: $37.64
transaction date
2026-07-02
Shares: 126,685
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Opaleye Management Inc., holds the title of 10% Owner at Eton Pharmaceuticals, Inc..
On 2026-07-02, the insider transacted 126,685 shares.The shares were transacted at a weighted average price of $37.64 per share, resulting in a total market-relevant value of $4.8M.
Executive Summary Summary
Opaleye Management Inc. (10% Owner) sold $4.8M of $ETON
Post-Transaction Position: 2,710,000 shares
SEC Accession No: 0001493152-26-032394 (CIK: 1595855)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.